Qiagen announces the acquisition of an enabling technology for enrichment and molecular analysis of circulating tumor cells (CTCs) from blood samples

March 17, 2015 Leave a comment 3,369 Views

GERMANTOWN, Maryland, and HILDEN, Germany, March 16, 2015 /PRNewswire/ — Acquisition of technology from AdnaGen enables use of innovative, non-invasive blood tests to analyze circulating tumor cells (CTCs) for personalized healthcare QIAGEN and Tokai Pharmaceuticals to co-develop and commercialize the ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: AdnaGen

Qiagen announces the acquisition of an enabling technology for enrichment and molecular analysis of circulating tumor cells (CTCs) from blood samples

Scientists explain regulation of extracellular vesicles by dephosphorylating Syntenin

Overcoming Chemoresistance via Extracellular Vesicle Inhibition

Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential

Study focuses on a different kind of liquid biopsy to detect cancer

Raman spectral signatures of serum-derived EVs may serve as liquid biopsy for diagnosis of CNS tumors

Extracellular vesicles isolated from milk can improve gut barrier dysfunction induced by malnutrition